Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patients - Top-Institutions - MDSpire

Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patients

  • By

  • Xichun Qin

  • Bo Cheng

  • Shangshang Ma

  • Kun Li

  • Yongfei Fan

  • Mingjun Li

  • Rangrang Wang

  • Xuefeng Ai

  • Leilei Wu

  • Xiucheng Liu

  • Xiaojin Wu

  • Dong Xie

  • November 17, 2025

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Oncology
    • Psycho-Oncology
    • Translational Cancer Research
  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Oncology
    • Psychiatry and Behavioral Sciences
    • Clinical Trials
  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Psychosocial Oncology
    • Cancer Pharmacology
  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Thoracic Surgery
    • Psychiatry
    • Cancer Clinical Research

Original Source(s)

Related Content